Trial intelligence / Profile preview

PREFER-FET progesterone dose trial in modified natural-cycle frozen embryo transfer

jRCT1031260558Not yet recruiting

Start
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in infertility comparing Luteum 800 mg/day with OneCrinone 90 mg/day (2 arms). Primary endpoint: Live birth rate. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

progesteroneCrinone
03

Conditions

infertility

Beyond the preview

Go deeper on jRCT1031260558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031260558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call